Why is Poly Medicure Ltd ?
1
The company is Net-Debt Free
2
Poor long term growth as Operating profit has grown by an annual rate 14.39% of over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
- INTEREST(Latest six months) At Rs 12.91 cr has Grown at 44.57%
- ROCE(HY) Lowest at 13.08%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 87.87 cr
4
With ROE of 10.5, it has a Very Expensive valuation with a 5.8 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.02%, its profits have fallen by -10.5%
5
High Institutional Holdings at 21.64%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 5.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -8.02% returns
7
With its market cap of Rs 17,201 cr, it is the second biggest company in the sector (behind Lenskart Solut.)and constitutes 12.77% of the entire sector
- Its annual Sales of Rs 1,997.43 are 15.80% of the industry
How much should you hold?
- Overall Portfolio exposure to Poly Medicure should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Poly Medicure for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Poly Medicure
-8.04%
-0.19
42.96%
Sensex
-1.65%
-0.12
13.58%
Quality key factors
Factor
Value
Sales Growth (5y)
19.26%
EBIT Growth (5y)
13.82%
EBIT to Interest (avg)
32.41
Debt to EBITDA (avg)
0.54
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.70
Tax Ratio
25.82%
Dividend Payout Ratio
10.48%
Pledged Shares
0
Institutional Holding
21.64%
ROCE (avg)
19.46%
ROE (avg)
13.65%
Valuation Key Factors 
Factor
Value
P/E Ratio
56
Industry P/E
103
Price to Book Value
5.77
EV to EBIT
52.36
EV to EBITDA
37.82
EV to Capital Employed
6.63
EV to Sales
8.73
PEG Ratio
NA
Dividend Yield
0.20%
ROCE (Latest)
12.41%
ROE (Latest)
10.53%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
Technical Movement
7What is working for the Company
NET SALES(Q)
At Rs 525.38 cr has Grown at 30.30%
PBDIT(Q)
Highest at Rs 125.10 cr.
-16What is not working for the Company
INTEREST(Latest six months)
At Rs 12.91 cr has Grown at 44.57%
ROCE(HY)
Lowest at 13.08%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 87.87 cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.53 times
PAT(Q)
At Rs 86.03 cr has Fallen at -7.6%
Loading Valuation Snapshot...
Here's what is working for Poly Medicure
Net Sales - Quarterly
At Rs 525.38 cr has Grown at 30.30%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 125.10 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Here's what is not working for Poly Medicure
Interest - Latest six months
At Rs 12.91 cr has Grown at 44.57%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit After Tax (PAT) - Quarterly
At Rs 86.03 cr has Fallen at -7.6%
Year on Year (YoY)MOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 87.87 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Lowest at 3.53 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio






